Abstract
AbstractEffective therapies for obesity either require invasive surgical or endoscopic interventions or high patient adherence, making it challenging for the nearly 42% of American adults who suffer from obesity to effectively manage their disease. Gastric mechanoreceptors sense distension of the stomach and perform volume-dependent vagal signaling to initiate the gastric phase and influence satiety. In this study, we developed a new luminal stimulation modality to specifically activate these gastric stretch receptors to elicit a vagal afferent response commensurate with mechanical distension. Here we developed the Vibrating Ingestible BioElectronic Stimulator (VIBES) pill - an ingestible device that performs luminal vibratory stimulation to activate mechanoreceptors and stroke mucosal receptors, which induces serotonin release as well as yields a hormonal metabolic response commensurate with a fed state. We evaluated VIBES across 108 meals in swine which consistently led to diminished food intake (∼40%, p< 0.0001) and minimized the weight gain rate (p< 0.03) as compared to untreated controls. Application of mechanoreceptor biology could transform our capacity to help patients suffering from nutritional disorders.
Publisher
Cold Spring Harbor Laboratory
Reference50 articles.
1. CDC, Obesity is a Common, Serious, and Costly DiseaseCent. Dis. Control Prev. (2022) (available at https://www.cdc.gov/obesity/data/adult.html).
2. Overweight & Obesity Statistics | NIDDKNatl. Inst. Diabetes Dig. Kidney Dis. (available at https://www.niddk.nih.gov/health-information/health-statistics/overweight-obesity).
3. Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss;Obes. Silver Spring Md,2019
4. Health Effects of Overweight and Obesity in 195 Countries over 25 Years
5. Cost-effectiveness of bariatric surgery and non-surgical weight management programmes for adults with severe obesity: a decision analysis model;Int. J. Obes,2021